Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14879736 | 1.00 | CYP3A4 (0.36) | CYP3A4MAPTRECQLTRPA1GAA | |
| SCHEMBL14879813 | 1.00 | CYP3A4 (0.36) | CYP3A4MAPTRECQLTRPA1GAA | |
| SCHEMBL6066010 | 0.67 | CYP3A4 (0.33) | CYP3A4MAPTRECQL | |
| SCHEMBL3697329 | 0.65 | CYP3A4 (0.41) | CYP3A4MAPTRECQLTRPA1ALDH1A1 | |
| SCHEMBL31410914 | 0.63 | PTPN1 (0.35) | CYP3A4MAPTRECQLALDH1A1 | |
| SCHEMBL4220894 | 0.63 | EBP (0.42) | MAPTGAAALDH1A1 | |
| SCHEMBL11797090 | 0.63 | PTPN1 (0.35) | CYP3A4MAPTRECQLALDH1A1 | |
| SCHEMBL7615076 | 0.63 | SMN1; SMN2 (0.37) | CYP3A4MAPTRECQLALDH1A1 | |
| SCHEMBL14881899 | 0.63 | CYP3A4 (0.36) | CYP3A4MAPTRECQL | |
| SCHEMBL731702 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170137398-A1 | OPSIN-BINDING LIGANDS, COMPOSITIONS AND METHODS OF USE | BIKAM PHARMACEUTICALS, INC. (US) | 2017-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170137398-A1 | OPSIN-BINDING LIGANDS, COMPOSITIONS AND METHODS OF USE | CRYAB, CRYAA, PDE6C | CYP3A4 4427/4885MAPT 1097/4885RECQL 1333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.